Other
Microbiome
Microbiome is an intervention with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Other(1)
Detailed Status
Completed2
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Trials by Status
completed240%
unknown120%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
recruiting
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
NCT06221800
recruiting
Biomarkers for Ventilator-associated Pneumonia
NCT05117125
unknown
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
NCT04636775
completed
Neonatal Microbiome Validity Study
NCT02655250
completed
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
NCT02984059
Clinical Trials (5)
Showing 5 of 5 trials
NCT06221800
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
NCT05117125
Biomarkers for Ventilator-associated Pneumonia
NCT04636775
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
NCT02655250
Neonatal Microbiome Validity Study
NCT02984059
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
All 5 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 5